Navigation Links
Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.

The U.S. Food and Drug Administration (FDA) have approved the drug Femara (letrozole) as drug for the treatment of patients suffering from breast cancer among post menopausal women//.

Various studies have been done before the approval of the drug. The result of these studies was published in the December 29 issue of New England Journal of Medicine.

It said that the Novartis drug Femara was very efficient in controlling the recurrence of breast cancer among post menopausal women.

This drug has to be given in the initial therapy after surgery instead of Tamoxifen. This drug is of great importance to both the patients and the clinicians.

The drug is an aromatase inhibitor and prevents/inhibits the production of estrogen hormone. This hormone is the main culprit in inducing post menopausal breast cancers.

This drug is a boon and very useful to all these women suffering from breast cancers which have spread to the lymph nodes and also for women who are done with their chemotherapy.

The main point to be clearly understood by both the patients and clinicians is that the drug has to be prescribed only to postmenopausal women. The reason being that the drug is only effective in these women. If taken by other women will result in fetal damage.

The company has already clearly outlined its side effects which are night sweats, weight gain, joint pain and hot flashes.

This drug is here to stay and help in the treatment of post menopausal breast cancers and advanced breast cancers.


'"/>




Page: 1

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Wonder drug - could end in disaster
3. Have You Ever Wondered How We Perceive Different Sounds?
4. Soy Not Such A Wonder For Health?
5. Have You Ever Wondered Why Male And Female Voices Differ?
6. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
7. Wonder drug Dasatinib gives hopes to leukemia patients
8. Braces Work Wonders In Setting Crooked Teeth Right
9. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
10. Save Budhia - The Indian Wonder Kid
11. Wonder Drug For Weight Loss Launched In UK
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... , ... June 23, 2017 , ... MD Now ... This is MD Now’s 28th facility overall and marks the urgent care center's eighth ... one mile North of The Falls shopping mall. The new clinic offers a wide ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance Agency ... the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more people ... the Biggert-Waters Act was enacted to reflect the actual risk in flood zone ...
(Date:6/23/2017)... Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... on 26th June, 2017 from 9 am to 3 pm to present to graduate ... The program is an original curriculum project led by The Health Improvement Service ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... assistance and financial planning services to communities in the greater Chicago metropolitan area, ... to offer assistance to underprivileged youth in Chicago. , Founded in 1897, Hephzibah ...
(Date:6/23/2017)... Morgantown, WV (PRWEB) , ... June 23, 2017 ... ... asset protection services and personal financial planning to families and business owners in ... Stepping Stones organization to help provide services to differently abled residents in the ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: